Legend Biotech Corp (LEGN)
40.94
+1.19
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
40.95
+0.01
(+0.02%)
After-Hours: 20:00
Legend Biotech Total Liabilities (Quarterly): 619.72M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 619.72M |
| June 30, 2024 | 639.18M |
| March 31, 2024 | 611.05M |
| December 31, 2023 | 597.24M |
| September 30, 2023 | 499.70M |
| June 30, 2023 | 523.63M |
| March 31, 2023 | 556.20M |
| December 31, 2022 | 586.65M |
| June 30, 2022 | 460.11M |
| Date | Value |
|---|---|
| March 31, 2022 | 601.95M |
| December 31, 2021 | 353.52M |
| September 30, 2021 | 587.90M |
| March 31, 2021 | 408.80M |
| December 31, 2020 | 124.32M |
| September 30, 2020 | 373.74M |
| June 30, 2020 | 371.86M |
| March 31, 2020 | 380.82M |
| December 31, 2019 | 410.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
124.32M
Minimum
Dec 2020
639.18M
Maximum
Jun 2024
483.72M
Average
511.66M
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 108.13B |
| Ligand Pharmaceuticals Inc | 113.69M |
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 10.68M |
| IGC Pharma Inc | 2.992M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.736B |
| Shareholders Equity (Quarterly) | 1.116B |
| Debt to Equity Ratio | 0.2658 |
| Current Ratio | 4.984 |
| Net Debt Paydown Yield | -0.06% |